Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 15
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
10/1/1988
1.
Phase III Randomized, Placebo-Controlled Study of Beta-Carotene and Vitamin E in the Prevention of Lung Cancer (Summary Last Modified 10/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Prevention
Closed
50 to 69
DCPC-CPSB-10005
Last Modified:
10/1/1988
2.
Study of the Effect of Nutritional Intervention on Esophageal Cancer in Linxian, People's Republic of China (Summary Last Modified 10/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Prevention
Completed
40 to 69
DCPC-CPSB-11204
Last Modified:
8/1/1990
3.
Phase III Study of Radiotherapy Alone vs Radiotherapy plus Oral Beta-Carotene in Patients with Advanced Cancer of the Head and Neck
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care, Treatment
Closed
any age
UCHSC-88251
NCI-V89-0098
Last Modified:
8/1/1993
4.
Phase III Randomized Placebo-Controlled Study of Beta Carotene for Chemoprevention of Second Primaries in Patients with Stage I/II Head and Neck Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Prevention
Closed
adult
NCI
SWOG-9043
NCI-P93-0039
Last Modified:
1/1/1990
5.
Phase II Study of Isotretinoin (Ro4-3780) with Randomization to Isotretinoin or Beta Carotene Treatment in Patients with Premalignant Lesions of the Oral Cavity (Summary Last Modified 01/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Prevention
Closed
15 and over
MDA-DM-87017
NCI-P89-0001
Last Modified:
11/1/1992
6.
Phase II Study of Beta Carotene with Randomization to No Treatment or Beta Carotene Maintenance in Patients with Premalignant Lesions of the Oral Cavity (Summary Last Modified 11/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Prevention
Closed
18 and over
UARIZ-8979
NCI-P92-0012
Last Modified:
9/5/2008
7.
Phase II, Randomized, Placebo-controlled Study of Beta-Carotene for Chemoprevention of Premalignant Cervical Cancer (Summary Last Modified 06/93)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Prevention
Closed
21 to 60
NCI
UCI-90146
NCI-P92-0016
8.
Safety of Antioxidants During GYN Cancer Care
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
No age specified
Other
10006
NCT00284427
Last Modified:
11/9/2007
9.
Randomized, Placebo-Controlled Study of Beta Carotene, Vitamin E, and Aspirin for Chemoprevention of Cancer and Cardiovascular Disease in Women
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Prevention
Closed
45 and over
NCI, NHLBI
BWH-WHS
BWH-1999-P-001304, BWH-2004-P-001661, BWH-88-02744, NCI-P92-0024, NCT00000479
Last Modified:
6/1/1993
10.
Randomized, Placebo-Controlled Study of Beta Carotene for Chemoprevention of Premalignant Cervical Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Prevention
Closed
16 to 65
AECM-CCI90-140
NCI-P92-0025
Select All on One Page
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute